Generation of a Zebrafish Knock-In Model Recapitulating Childhood ETV6::RUNX1-Positive B-Cell Precursor Acute Lymphoblastic Leukemia

被引:0
|
作者
Zapilko, Veronika [1 ]
Moisio, Sanni [2 ]
Parikka, Mataleena [3 ]
Heinaniemi, Merja [2 ]
Lohi, Olli [1 ,4 ,5 ]
机构
[1] Tampere Univ, Fac Med & Hlth Technol, Tampere Ctr Child Adolescent & Maternal Hlth Res, Tampere 33100, Finland
[2] Univ Eastern Finland, Inst Biomed, Kuopio 70210, Finland
[3] Tampere Univ, Fac Med & Hlth Technol, Lab Infect Biol, Tampere 33100, Finland
[4] Tampere Univ Hosp, Dept Pediat, Wellbeing Serv Cty Pirkanmaa, Tampere 33520, Finland
[5] Tampere Univ Hosp, Tays Canc Ctr, Wellbeing Serv Cty Pirkanmaa, Tampere 33520, Finland
基金
芬兰科学院;
关键词
childhood pB-ALL; disease model; CRISPR/Cas9-based knock-in; zebrafish; CHROMOSOME TRANSLOCATIONS; EMBRYONIC-DEVELOPMENT; TEL GENE; TEL-AML1; FUSION; MECHANISMS; TRANSPOSON; EVOLUTION; REARRANGEMENTS; HEMATOPOIESIS;
D O I
10.3390/cancers15245821
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Despite remarkable progress in the treatment of acute lymphoblastic leukemia (ALL) in recent years, it remains a significant contributor to pediatric cancer-related deaths. This highlights the urgent need for innovative therapeutic strategies that target the genetic alterations driving ALL. We built a novel zebrafish disease model for ETV6::RUNX1-positive ALL, which harbors secondary lesions in the two commonly mutated genes, pax5, and cdkn2a/b. The introduction of secondary mutations significantly augmented the incidence of disease. This model provides a valuable tool for investigating the etiological role of secondary mutations and facilitating the evaluation of drug sensitivities in the future.Abstract Approximately 25% of children with B-cell precursor acute lymphoblastic leukemia (pB-ALL) harbor the t(12;21)(p13;q22) translocation, leading to the ETV6::RUNX1 (E::R) fusion gene. This translocation occurs in utero, but the disease is much less common than the prevalence of the fusion in newborns, suggesting that secondary mutations are required for overt leukemia. The role of these secondary mutations remains unclear and may contribute to treatment resistance and disease recurrence. We developed a zebrafish model for E::R leukemia using CRISPR/Cas9 to introduce the human RUNX1 gene into zebrafish etv6 intron 5, resulting in E::R fusion gene expression controlled by the endogenous etv6 promoter. As seen by GFP fluorescence at a single-cell level, the model correctly expressed the fusion protein in the right places in zebrafish embryos. The E::R fusion expression induced an expansion of the progenitor cell pool and led to a low 2% frequency of leukemia. The introduction of targeted pax5 and cdkn2a/b gene mutations, mimicking secondary mutations, in the E::R line significantly increased the incidence in leukemia. Transcriptomics revealed that the E::R;pax5mut leukemias exclusively represented B-lineage disease. This novel E::R zebrafish model faithfully recapitulates human disease and offers a valuable tool for a more detailed analysis of disease biology in this subtype.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Pathogenesis of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia and mechanisms underlying its relapse
    Sun, Congcong
    Chang, Lixian
    Zhu, Xiaofan
    ONCOTARGET, 2017, 8 (21) : 35445 - 35459
  • [2] ETV6/RUNX1-positive childhood acute lymphoblastic leukemia (ALL): The spectrum of clonal heterogeneity and its impact on prognosis
    Ampatzidou, M.
    Papadhimitriou, S. I.
    Paterakis, G.
    Pavlidis, D.
    Tsitsikas, K.
    Kostopoulos, I. V.
    Papadakis, V.
    Vassilopoulos, G.
    Polychronopoulou, S.
    CANCER GENETICS, 2018, 224 : 1 - 11
  • [3] ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol
    Wang, Yu
    Zeng, Hui-min
    Zhang, Le-ping
    ITALIAN JOURNAL OF PEDIATRICS, 2018, 44
  • [4] Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia
    Bokemeyer, Almut
    Eckert, Cornelia
    Meyr, Franziska
    Koerner, Gabriele
    von Stackelberg, Arend
    Ullmann, Reinhard
    Tuerkmen, Seval
    Henze, Guenter
    Seeger, Karl
    HAEMATOLOGICA, 2014, 99 (04) : 706 - 714
  • [5] Siblings with ETV6/RUNX1-positive B-lymphoblastic leukemia: A single site experience and review of the literature
    Martig, Daniel S.
    Williamson, Cynthia M.
    Xu, Xinjie
    Sukov, William R.
    Greipp, Patricia T.
    Hoppman, Nicole L.
    Baughn, Linda B.
    Ketterling, Rhett P.
    Peterson, Jess F.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2020, 48
  • [6] Cytokine Hyperresponsiveness in Children With ETV6::RUNX1-positive Acute Lymphoblastic Leukemia After Challenge With Common Pathogens
    Ruechel, Nadine
    Oldenburg, Marina
    Janssen, Stefan
    Pandyra, Aleksandra A.
    Liu, Wei
    Vasileiou, Eleni
    Hein, Daniel
    Jepsen, Vera Helena
    Fischer, Ute
    Picard, Daniel
    Koegler, Gesine
    Hauer, Julia
    Auer, Franziska
    Beer, Angelina
    Adams, Ortwin
    MacKenzie, Colin
    Jaeger, Martin
    Netea, Mihai G.
    Borkhardt, Arndt
    Gossling, Katharina L.
    HEMASPHERE, 2023, 7 (02):
  • [7] Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia
    Ghazavi, Farzaneh
    De Moerloose, Barbara
    Van Loocke, Wouter
    Wallaert, Annelynn
    Helsmoortel, Hetty H.
    Ferster, Alina
    Bakkus, Marleen
    Plat, Genevieve
    Delabesse, Eric
    Uyttebroeck, Anne
    Van Nieuwerburgh, Filip
    Deforce, Dieter
    Van Roy, Nadine
    Speleman, Frank
    Benoit, Yves
    Lammens, Tim
    Van Vlierberghe, Pieter
    ONCOTARGET, 2016, 7 (45) : 73769 - 73780
  • [8] Prognostic impact of RUNX1 and ETV6 gene copy number on pediatric B-cell precursor acute lymphoblastic leukemia with or without hyperdiploidy
    Kutlay, Nuket Yurur
    Pekpak, Esra
    Altiner, Sule
    Ileri, Talia
    Vicdan, Arzu Nedime
    Dincaslan, Handan
    Ince, Elif Unal
    Tukun, Fatma Ajlan
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 104 (03) : 368 - 377
  • [9] ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy
    Bhojwani, D.
    Pei, D.
    Sandlund, J. T.
    Jeha, S.
    Ribeiro, R. C.
    Rubnitz, J. E.
    Raimondi, S. C.
    Shurtleff, S.
    Onciu, M.
    Cheng, C.
    Coustan-Smith, E.
    Bowman, W. P.
    Howard, S. C.
    Metzger, M. L.
    Inaba, H.
    Leung, W.
    Evans, W. E.
    Campana, D.
    Relling, M. V.
    Pui, C-H
    LEUKEMIA, 2012, 26 (02) : 265 - 270
  • [10] Prognostic Value and Outcome for ETV6/RUNX1-Positive Pediatric Acute Lymphoblastic Leukemia: A Report From the South China Children's Leukemia Group
    Qiu, Kun-yin
    Xu, Hong-gui
    Luo, Xue-qun
    Mai, Hui-rong
    Liao, Ning
    Yang, Li-hua
    Zheng, Min-cui
    Wan, Wu-qing
    Wu, Xue-dong
    Liu, Ri-yang
    Chen, Qi-wen
    Chen, Hui-qin
    Sun, Xiao-fei
    Jiang, Hua
    Long, Xing-jiang
    Chen, Guo-hua
    Li, Xin-yu
    Li, Chang-gang
    Huang, Li-bin
    Ling, Ya-yun
    Lin, Dan-na
    Wen, Chuan
    Kuang, Wen-yong
    Feng, Xiao-qin
    Ye, Zhong-lv
    Wu, Bei-yan
    He, Xiang-lin
    Li, Qiao-ru
    Wang, Li-na
    Kong, Xian-ling
    Xu, Lu-hong
    Li, Chi-kong
    Fang, Jian-pei
    FRONTIERS IN ONCOLOGY, 2021, 11